Delivered-To: ouchendans62@gmail.com
Received: by 2002:ac0:fa0b:0:b0:2da:d504:b4a4 with SMTP id g11csp577552ims;
        Tue, 30 May 2023 11:05:05 -0700 (PDT)
X-Google-Smtp-Source: ACHHUZ7p5uai2P6QbTATN8RWFc6K1SV3zlvnAeRATyw5Bipyzgz6T3XAD4LXLeCyP6S0TuT8AFQ2
X-Received: by 2002:a05:6808:128f:b0:398:2e49:a0da with SMTP id a15-20020a056808128f00b003982e49a0damr2481171oiw.30.1685469904809;
        Tue, 30 May 2023 11:05:04 -0700 (PDT)
ARC-Seal: i=1; a=rsa-sha256; t=1685469904; cv=none;
        d=google.com; s=arc-20160816;
        b=dG9GFwRdPCqA2/jBsIjAGy48fRGMdiVLgjftUFLIM3RRJyzJwoxTMSA/vQM0Py/JMC
         dX73WV2xYKUxzVqaUC58Ac0BskfFoqa7HlvxZNaYX3nbvTuEHTost8wu1q8rgxsLChVr
         hCxgDAAzPIP+biqApJVivArGQD+J0mwMHePOZ7+NwnzMvlvg3Et7K9STcYgutns6zEgQ
         LNHf6bi/YEnRCUXvl2KUSl4JZrVEQ8VPrbp8A1Dpi807sfu0wrndi70j+zldswOiRj0K
         d4SPDas9KEUnfDL6/hHceckfLbIgtxwBKZqAtZp9WA65KIO+b2gKxdGfJhhG23kmoQBE
         1jpw==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=feedback-id:message-id:list-id:reply-to:mime-version
         :list-unsubscribe-post:list-unsubscribe:date:subject:to:from
         :dkim-signature;
        bh=PC+RcoyDmicSy4gj3ZZ3aUGdwnK986yryu8zVN8ofUY=;
        b=LAj3bYbWHqDn0czCJ25DfhleIt3np6Ta1K8HX7sFaM8Nih0K4fwf8+Wq4pj4TWYq6i
         hiTGEK0He0Mcqo6+ZF2nlOYdqN5AS6Bchr3eE6IRfJS8kX8mJxwRZCOmnNnHFKKoT1tR
         K1JXbTWAsHtpzdbk2N/bRmGp1SRnrbyospByPk9c5sK0cLjeQOhury7JGsmDYxVkqzOj
         LgNf/2FRR430Z0+Bgq05tFGaNslUzo8w4Y/IIt9+FDEq86lJwPWGabT42hIwC68p2xdj
         AUVb9nLR3C0dWyEN13V7nA+xkG7ENw0Li0ETLjuJumDKchAGVUtCdFh9yUiyQydT/9E/
         EMEQ==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@email.politico.com header.s=200608 header.b=SXCwvkBN;
       spf=pass (google.com: domain of bounce-2679572_html-1405096349-9801723-1376319-0@bounce.politicoemail.com designates 68.232.198.10 as permitted sender) smtp.mailfrom=bounce-2679572_HTML-1405096349-9801723-1376319-0@bounce.politicoemail.com;
       dmarc=pass (p=QUARANTINE sp=QUARANTINE dis=NONE) header.from=email.politico.com
Return-Path: <bounce-2679572_HTML-1405096349-9801723-1376319-0@bounce.politicoemail.com>
Received: from mta.politicoemail.com (mta.politicoemail.com. [68.232.198.10])
        by mx.google.com with ESMTPS id u187-20020a4a21c4000000b0055804452a09si3846730oou.46.2023.05.30.11.05.03
        for <ouchendans62@gmail.com>
        (version=TLS1_2 cipher=ECDHE-ECDSA-AES128-GCM-SHA256 bits=128/128);
        Tue, 30 May 2023 11:05:04 -0700 (PDT)
Received-SPF: pass (google.com: domain of bounce-2679572_html-1405096349-9801723-1376319-0@bounce.politicoemail.com designates 68.232.198.10 as permitted sender) client-ip=68.232.198.10;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@email.politico.com header.s=200608 header.b=SXCwvkBN;
       spf=pass (google.com: domain of bounce-2679572_html-1405096349-9801723-1376319-0@bounce.politicoemail.com designates 68.232.198.10 as permitted sender) smtp.mailfrom=bounce-2679572_HTML-1405096349-9801723-1376319-0@bounce.politicoemail.com;
       dmarc=pass (p=QUARANTINE sp=QUARANTINE dis=NONE) header.from=email.politico.com
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; s=200608; d=email.politico.com;
 h=From:To:Subject:Date:List-Unsubscribe:List-Unsubscribe-Post:MIME-Version:
 Reply-To:List-ID:X-CSA-Complaints:Message-ID:Content-Type;
 i=futurepulse@email.politico.com;
 bh=PC+RcoyDmicSy4gj3ZZ3aUGdwnK986yryu8zVN8ofUY=;
 b=SXCwvkBNSpaxE3XFa1dH9UrGLbubiWbBM5H8hyHtE9241J1Kf9pIDH84DNjvQEKaeRcf17eGmh3Y
   zTYhw7khNhssrS23cWyWo02XYU9HQ9UKzfZGPfQ8E9/M6TK4ED+h7njalHuuUIROMKTErlIJQiCV
   ZeLH1DkEZG3VHuq6NpI=
Received: by mta.politicoemail.com id heotd02fmd45 for <ouchendans62@gmail.com>; Tue, 30 May 2023 18:02:08 +0000 (envelope-from <bounce-2679572_HTML-1405096349-9801723-1376319-0@bounce.politicoemail.com>)
From: "POLITICO Future Pulse" <futurepulse@email.politico.com>
To: <ouchendans62@gmail.com>
Subject: A drug price negotiation architect speaks
Date: Tue, 30 May 2023 12:02:08 -0600
List-Unsubscribe: <https://click.politicoemail.com/subscription_center.aspx?jwt=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJtaWQiOiIxMzc2MzE5IiwicyI6IjE0MDUwOTYzNDkiLCJsaWQiOiIyNjc5NTcyIiwiaiI6Ijk4MDE3MjMiLCJqYiI6IjAiLCJkIjoiNDAxMjYifQ.DGkwUXC8J7yp9qfOSlyYA_PRCMmzmpHiaw27JYZ_iu8>, <mailto:leave-fc751676726d017a777b28313958-fdf61574756104747317747c-fe911d787565037f76-fe9115737262077c7c-ffcf14@leave.politicoemail.com>
List-Unsubscribe-Post: List-Unsubscribe=One-Click
x-CSA-Compliance-Source: SFMC
MIME-Version: 1.0
Reply-To: "POLITICO, LLC" <reply-fe911d787565037f76-2679572_HTML-1405096349-1376319-0@politicoemail.com>
List-ID: <1376319.xt.local>
X-CSA-Complaints: csa-complaints@eco.de
X-SFMC-Stack: 4
x-job: 1376319_9801723
Message-ID: <be821ef9-e06b-410d-848f-cc185d2707aa@las1s04mta952.xt.local>
Feedback-ID: 1376319:9801723:68.232.198.10:sfmktgcld
Content-Type: multipart/alternative;
	boundary="hsA5nR10H75w=_?:"

This is a multi-part message in MIME format.

--hsA5nR10H75w=_?:
Content-Type: text/plain;
	charset="utf-8"
Content-Transfer-Encoding: 8bit

The ideas and innovators shaping health care May 30, 2023 View in browser  
By Erin Schumaker, Ben Leonard and Carmen Paun
 THE REGULATORS


John Barkett has some thoughts on Medicare drug price negotiation. | Courtesy of John Barkett

John Barkett was an architect of the Inflation Reduction Act’s landmark drug pricing provisions, which for the first time tasks Medicare with negotiating lower charges for some drugs.

It’s drawn the ire of the pharmaceutical industry, which argues it undermines innovation.

Barkett, who served in the Biden administration's Domestic Policy Council as a senior policy adviser and worked on the Affordable Care Act, recently moved to consulting firm Berkeley Research Group’s health care transactions and strategy practice in a senior role, where he’ll advise clients on the impact of health policy.

Ben caught up with him to discuss how the Centers for Medicare and Medicaid Services is implementing the law.

This interview has been edited for length and clarity. 

Pharmaceutical companies have criticized CMS for moving too quickly. What do you think?

CMS is striking the balance required to get input when appropriate, but also meet the really tight deadlines the IRA requires. You’ve got a year to set up brand new competency within CMS, hire the people, create the structure, set out the ground rules and analyze the data. And that’s just for the Medicare negotiation parts.

If they’re requesting comments in 30 days, that’s because that’s the time they had in order to meet other deadlines. It doesn’t represent any arrogance or disregard of stakeholders.

What do you see as the biggest challenges for IRA implementation going forward?

It’s a tight time frame and these laws aren’t self-executing. It’s also a complicated feedback environment.

They’re using authorities to move quickly. That’s a double-edged sword. It’s good to get feedback but they’re under a microscope.

When you were crafting the legislation, what was it like dealing with industry criticism? 

It’s not for the faint of heart.

The tension was between access and innovation. It was focusing on trying to improve access today while keeping in mind potential effects on innovation.

Not every policy in there is one that the pharmaceutical industry doesn’t like. It's not hard to find examples of companies saying that capping what Medicare beneficiaries pay at the pharmacy is going to help more beneficiaries access the drugs. They'll tell Wall Street that is going to lead to higher profits.

The industry is critical of Congress’ decision to exclude small-molecule drugs from negotiation for nine years, versus 13 for biologics. What’s your response to that? 

If you take the industry at their word, if they’re looking at development, one of the limiting factors on future revenues is how soon a drug might be negotiated.

That said, today you get five years of exclusivity for a small molecule drug and 12 years of exclusivity for a biologic. Arguably, those exclusivities have a bigger impact on potential profits than when negotiation occurs. I can't recall ever hearing these arguments made about exclusivities in the past.

  
DON’T MISS POLITICO’S HEALTH CARE SUMMIT: The Covid-19 pandemic helped spur innovation in health care, from the wide adoption of telemedicine, health apps and online pharmacies to mRNA vaccines. But what will the next health care innovations look like? Join POLITICO on Wednesday June 7 for our Health Care Summit to explore how tech and innovation are transforming care and the challenges ahead for access and delivery in the United States. REGISTER NOW.
     WELCOME TO FUTURE PULSE


New Harbor, Maine | Sam Oates

This is where we explore the ideas and innovators shaping health care.

Industry leaders and experts are warning that “mitigating the risk of extinction” from artificial intelligence should be a top priority, like preventing pandemics and nuclear war.

Share any thoughts, news, tips and feedback with Ben Leonard at bleonard@politico.com, Ruth Reader at rreader@politico.com, Carmen Paun at cpaun@politico.com or Erin Schumaker at eschumaker@politico.com.

Send tips securely through SecureDrop, Signal, Telegram or WhatsApp.

Today on our Pulse Check podcast, host Daniel Payne speaks with Alice Miranda Ollstein about her report on an Alabama clinic’s struggle to serve patients in a state with a total abortion ban.


Listen to today’s Pulse Check podcast
 DANGER ZONE 


A new study paints a bleak picture of kids' mental health. | Seth Wenig/AP Photo

It’s common knowledge that kids’ mental health has declined, but new research measures the severity — and it’s bad.

Between 2016 and 2022, kids and young adults saw inpatient hospital admissions related to mental health more than double, according to an analysis by the Clarify Health Institute.

The hospital admission stats are grim:

— Anxiety and “fear-related disorders” spiked 250 percent.

— Eating disorders, including those related to an inability to eat, increased 221 percent.

— Depression and related ailments went up 96 percent.

— Suicide attempts, suicidal ideation and self-harm rose 74 percent.

Diagnosis: The pandemic and the measures used to control it appeared to worsen preexisting trends.

The researchers also pointed to social media as a potential cause.

Response: The researchers said the rise in inpatient care is partly a result of the failures of outpatient providers early on.

“The most effective approach to pediatric mental health care likely involves a combination of inpatient and outpatient services, with patients transitioning between levels of care based on their individual needs and the severity of their conditions,” the researchers said.

Lawmakers in Washington have zeroed in on social media, but it’s unclear what tangible steps they’ll take.

  
GET READY FOR GLOBAL TECH DAY: Join POLITICO Live as we launch our first Global Tech Day alongside London Tech Week on Thursday, June 15. Register now for continuing updates and to be a part of this momentous and program-packed day! From the blockchain, to AI, and autonomous vehicles, technology is changing how power is exercised around the world, so who will write the rules? REGISTER HERE.
     WASHINGTON WATCH


Kaine wants to ensure the military is doing all it can to prevent fentanyl trafficking. | John C. Clark/AP Photo

GOP lawmakers have introduced legislation to authorize the bombing of fentanyl labs in Mexico.

That’s unacceptable to Democrats on Capitol Hill, but there is support in their caucus for increasing Pentagon involvement in the fight against the deadly synthetic opioid.

How so? Tim Kaine (D-Va.) plans to join his Republican colleague Joni Ernst of Iowa in asking fellow senators on the Armed Services Committee to add a provision to the National Defense Authorization Act naming fentanyl trafficking a national security threat, Kaine told POLITICO.

The panel plans to consider the bill next month.

It would direct the Pentagon to develop a counterdrug strategy. And it would task Defense Secretary Lloyd Austin with seeking more cooperation from the Mexican military.

Ernst told POLITICO in an email that the bill is “a real solution to the deadly fentanyl crisis with bipartisan, bicameral support.”

Why it matters: Congress has passed a defense authorization bill for 62 consecutive years, so if Kaine and Ernst are successful, their amendment is likely to become law.
  
Follow us on Twitter

Ben Leonard @_BenLeonard_

Ruth Reader @RuthReader

Carmen Paun @carmenpaun

Erin Schumaker @erinlschumaker
  
Follow us
  
To change your alert settings, please log in at https://go.politicoemail.com/?qs=d8a27c8b492fb496b0f31e4da595e336f3e14e7e8dcda5cf5f4b4875d3a40ba63ce5c2fce09e98af3bd2797779cec63d27ce424236f4384a  https://click.politicoemail.com/profile_center.aspx?qs=9c775bb5bc5419bcb2e8309a5c29d12d93e82fe774a453a2aeb0863568da0b0445ea46dc136edbde9731f8c22fb1fe9dcec30ddbf8454048ac337c9575d919757078be78543c1048

This email was sent to ouchendans62@gmail.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

 Please click here and follow the steps to unsubscribe.
  

--hsA5nR10H75w=_?:
Content-Type: text/html;
	charset="utf-8"
Content-Transfer-Encoding: 8bit

<html><body><head>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
    <title></title>
    <!--[if gte mso 9]>
    <xml>
        <o:OfficeDocumentSettings>
            <o:AllowPNG/>
            <o:PixelsPerInch>96</o:PixelsPerInch>
        </o:OfficeDocumentSettings>
    </xml><![endif]-->
</head><!-- Everything above this line is "new" to the template. We'll have to experiment a bit to see if it causes troubles. --><!-- preview text --><div style="display:none;font-size:1px;color:#ffffff;line-height:1px;max-height:0px;max-width:0px;opacity:0;overflow:hidden;">    The ideas and innovators shaping health care</div><table border="0" cellpadding="0" cellspacing="0" width="100%" bgcolor="#ffffff" style="padding:5px 0 15px 0;margin:0;text-align:center" role="presentation">    <tbody>    <tr>        <td><!-- Note: This is left blank to aid in centering across email clients --></td>        <td align="center" width="540">            
<table width="100%" border="0" cellpadding="0" cellspacing="0" style="max-width:540px;table-layout:fixed;" role="presentation">                <tbody>                <!-- top date and utility link -->                <tr>    <td align="center">        <table width="100%" border="0" cellpadding="0" cellspacing="0" style="padding-bottom:15px;" role="presentation">            <tbody>            <tr>                <td width="50%" style="text-align:left;font-size:11px;font-family:Helvetica,sans-serif;color:#B1B4BD;margin:0;">May 30, 2023</td>                <td width="50%" style="text-align:right;font-size:11px;font-family:Helvetica,sans-serif;color:#B1B4BD;margin:0;"><a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496df628e2f2345a4d40b839898b737f4f7d40a779805e6b3f64ffcb70d9feaddd8f56b4573905b1225050d3fa1cea953bb" target="_blank" style="color:#007BC7;text-decoration:none;">View in browser</a
></td>            </tr>            </tbody>        </table>    </td></tr>                <!-- divider line -->                <tr>    <td height="20" style="height:20px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td></tr>                <!-- logo and byline -->                <tr>    <td align="center" style="text-align:center;padding:0 20px 15px 20px;margin:0">                                    <img src="https://static.politico.com/c7/9f/3d42f33b4473aec1aee4edf9a02b/politico-future-pulse.jpg" title="POLITICO_FUTURE_PULSE_Graphic_2.png" alt="Future Pulse" border="0" width="500" style="width:100%;max-width:500px;">                        </td></tr><tr>    
<td align="center" style="padding:0 20px 10px 20px;">        <p style="text-align:center;font-family:Helvetica,sans-serif;font-size:11px;letter-spacing:2px;color:#B1B4BD;text-transform:uppercase;margin:0;">            By  <a
 href="mailto:eschumaker@politico.com" target="_blank" style="color:#000000;text-decoration:none;font-weight:bold;">Erin Schumaker</a
>,  <a
 href="mailto:bleonard@politico.com" target="_blank" style="color:#000000;text-decoration:none;font-weight:bold;">Ben Leonard</a
> and  <a
 href="mailto:cpaun@politico.com" target="_blank" style="color:#000000;text-decoration:none;font-weight:bold;">Carmen Paun</a
>        </p>    </td></tr>                <!-- sponsor logo -->                                    <!-- body -->                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    </tr>                                    <tr>                        <td style="padding-bottom:10px; min-width:100%; width:100%;"><!-- Inline styling used, as its an email content --><table width="100%" cellpadding="0" cellspacing="0" border="0" role="presentation" style="background-color:#121522; min-width:100%;">    <tbody>    <tr>        
<td style="text-align:left;font-family:Helvetica,sans-serif;font-size:12px;color:#FFFFFF;text-transform:uppercase;font-weight:bold;letter-spacing:2px;padding-top:10px;padding-bottom:10px;padding-left:20px;margin:0;" valign="middle">THE REGULATORS</td>    </tr>    </tbody></table></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;">
<p align="center" style="margin:0 0 20px 0;"><img src="https://www.politico.com/dims4/default/b2abc45/2147483647/resize/1000x/quality/90/?url=https%3A%2F%2Fstatic.politico.com%2F96%2F38%2F6ee27dde49b2a9e5a166a790a3be%2Fbarkett-headshot.png" title="John" alt="John Barkett" width="500" style="width:100%;max-width:500px;"></p><p style="font-family:Helvetica,sans-serif;font-size:12px;color:#6E7381;margin-bottom:24px;">John Barkett has some thoughts on Medicare drug price negotiation.  |  Courtesy of John Barkett</p></td>                    </tr>                                    <tr>                        
<td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">John Barkett was an architect</strong
> of the Inflation Reduction Act&#8217;s landmark drug pricing provisions, which for the first time tasks Medicare with negotiating lower charges for some drugs.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">It&#8217;s drawn the ire of the pharmaceutical industry, which argues it undermines innovation.</p>
<p style="margin-top:0;margin-bottom:24px;line-height:24px;">Barkett, who served in the Biden administration's Domestic Policy Council as a senior policy adviser and worked on the Affordable Care Act, recently moved to consulting firm Berkeley Research Group&#8217;s health care transactions and strategy practice in a senior role, where he&#8217;ll advise clients on the impact of health policy.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">Ben caught up with him to discuss how the Centers for Medicare and Medicaid Services is implementing the law.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><i
>This interview has been edited for length and clarity.&nbsp;</i
></p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">Pharmaceutical companies have criticized CMS for moving too quickly. What do you think?</strong
></p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">CMS is striking the balance required to get input when appropriate, but also meet the really tight deadlines the IRA requires. You&#8217;ve got a year to set up brand new competency within CMS, hire the people, create the structure, set out the ground rules and analyze the data. And that&#8217;s just for the Medicare negotiation parts.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">If they&#8217;re requesting comments in 30 days, that&#8217;s because that&#8217;s the time they had in order to meet other deadlines. It doesn&#8217;t represent any arrogance or disregard of stakeholders.</p>
<p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">What do you see as the biggest challenges for IRA implementation going forward?</strong
></p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">It&#8217;s a tight time frame and these laws aren&#8217;t self-executing. It&#8217;s also a complicated feedback environment.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">They&#8217;re using authorities to move quickly. That&#8217;s a double-edged sword. It&#8217;s good to get feedback but they&#8217;re under a microscope.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">When you were crafting the legislation, what was it like dealing with industry criticism?&nbsp;</strong
></p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">It&#8217;s not for the faint of heart.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">The tension was between access and innovation. It was focusing on trying to improve access today while keeping in mind potential effects on innovation.</p>
<p style="margin-top:0;margin-bottom:24px;line-height:24px;">Not every policy in there is one that the pharmaceutical industry doesn&#8217;t like. It's not hard to find examples of companies saying that capping what Medicare beneficiaries pay at the pharmacy is going to help more beneficiaries access the drugs. They'll tell Wall Street that is going to lead to higher profits.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">The industry is critical of Congress&#8217; decision to exclude small-molecule drugs from negotiation for nine years, versus 13 for biologics. What&#8217;s your response to that?&nbsp;</strong
></p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">If you take the industry at their word, if they&#8217;re looking at development, one of the limiting factors on future revenues is how soon a drug might be negotiated.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">That said, today you get five years of exclusivity for a small molecule drug and 12 years of exclusivity for a biologic. Arguably, those exclusivities have a bigger impact on potential profits than when negotiation occurs. I can't recall ever hearing these arguments made about exclusivities in the past.<br></p></td>                    </tr>                                    
<tr>                        </tr><tr>    <td height="10" style="height:10px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td></tr><tr>    <td style="padding:20px 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;background-color:#FFFFFF;">                                    <p style="margin-top:0;margin-bottom:20px;line-height:24px;margin-bottom:20px;color:#000000;">                <strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">DON&#8217;T MISS POLITICO&#8217;S HEALTH CARE SUMMIT</strong
>: The Covid-19 pandemic helped spur innovation in health care, from the wide adoption of telemedicine, health apps and online pharmacies to mRNA vaccines. But what will the next health care innovations look like? Join POLITICO on Wednesday June 7 for our Health Care Summit to explore how tech and innovation are transforming care and the challenges ahead for access and delivery in the United States. <a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496ee6c7ff734441f16e795dcacabf152fbb3f39b9b6a45b5d1ac42f3d2c196ef0a94d2efcc9144a4b54839801d76aa752e" style="text-decoration:underline;color:#007BC7;">REGISTER NOW</a
>.            </p>            </td></tr><tr>    <td height="10" style="height:10px; font-size:0; border-bottom:1px solid #E5E7EB;">&nbsp;</td></tr><tr>    <td height="15" style="height:15px; font-size:0;">&nbsp;</td></tr>                                                        <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    </tr>                                    <tr>                        <td style="padding-bottom:10px; min-width:100%; width:100%;"><!-- Inline styling used, as its an email content -->
<table width="100%" cellpadding="0" cellspacing="0" border="0" role="presentation" style="background-color:#121522; min-width:100%;">    <tbody>    <tr>        <td style="text-align:left;font-family:Helvetica,sans-serif;font-size:12px;color:#FFFFFF;text-transform:uppercase;font-weight:bold;letter-spacing:2px;padding-top:10px;padding-bottom:10px;padding-left:20px;margin:0;" valign="middle">WELCOME TO FUTURE PULSE</td>    </tr>    </tbody></table></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    
</tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"><p align="center" style="margin:0 0 20px 0;"><img src="https://www.politico.com/dims4/default/30b0d9f/2147483647/resize/1000x/quality/90/?url=https%3A%2F%2Fstatic.politico.com%2F79%2Fa0%2Fe91fe9b241ddbdab1cc5ac57102c%2Fpxl-20230527-140621409.jpg" title="PXL_20230527_140621409.jpg" alt="New Harbor, Maine" width="500" style="width:100%;max-width:500px;"></p><p style="font-family:Helvetica,sans-serif;font-size:12px;color:#6E7381;margin-bottom:24px;">New Harbor, Maine  |  Sam Oates</p></td>                    
</tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">This is where we explore the ideas and innovators shaping health care.</strong
></p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><span style="color:#7343E9;font-weight:bold;font-family:sans-serif;">Industry leaders and</span> experts <a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496dd5f09d966dad5e8ee6a6db282883d4ed38ec7e2c5b754427ac8373afd50c287778dc2321663046bd38e7d1e5340afa4" target="_blank"><u>are warning that</u></a
> &#8220;mitigating the risk of extinction&#8221; from artificial intelligence should be a top priority, like preventing pandemics and nuclear war.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">Share any thoughts, news, tips and feedback with Ben Leonard at </strong
><a
 href="mailto:bleonard@politico.com" target="_blank"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;"><u>bleonard@politico.com</u></strong
></a
><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">, Ruth Reader at </strong
><a
 href="mailto:rreader@politico.com" target="_blank"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;"><u>rreader@politico.com</u></strong
></a
><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">, Carmen Paun at </strong
><a
 href="mailto:cpaun@politico.com" target="_blank"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;"><u>cpaun@politico.com</u></strong
></a
><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;"> or Erin Schumaker at </strong
><a
 href="mailto:eschumaker@politico.com" target="_blank"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;"><u>eschumaker@politico.com</u></strong
></a
><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">.</strong
></p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496fdc4fd95ef3f8f141dbfd4d9af151427ddf24026f6b082b0ddb153288b5fc7ffa8db1751b1266c1ae41283ceaa2f1df1" target="_blank"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;"><u>Send tips securely</u></strong
></a
><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;"> through SecureDrop, Signal, Telegram or WhatsApp.</strong
></p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><span style="color:#7343E9;font-weight:bold;font-family:sans-serif;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">Today on our</strong
></span> <a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496b47b518fe04abddb472758c30d6c157de2c057fd1800d4ceb43bd8115714324ed9e11ecadeff44ecbbde3cc034be755f" target="_blank"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">Pulse Check</strong
></a
> <span style="color:#7343E9;font-weight:bold;font-family:sans-serif;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">podcast,</strong
></span> host Daniel Payne speaks with Alice Miranda Ollstein about her report on an Alabama clinic&#8217;s struggle to serve patients in a state with a total abortion ban.<br></p></td>                    </tr>                                    <tr>                        <td style="padding-bottom:24px;">    <table width="100%" cellpadding="0" cellspacing="10" border="0" role="presentation" style="border-top:1px solid #E5E7EB;border-bottom:1px solid #E5E7EB;border-collapse: separate;">        <tbody>        <tr>            <td valign="top" style="width:40px;text-align:right;"><a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496b47b518fe04abddb472758c30d6c157de2c057fd1800d4ceb43bd8115714324ed9e11ecadeff44ecbbde3cc034be755f" target="_blank"><img src="https://static.politico.com/hosted/icon-headphones-red%402x.png" title="Play audio" alt="Play audio" width="30" border="0"></a
></td>            <td valign="middle" style="text-align:left;">                <p style="margin:0;font-family:Helvetica,sans-serif;font-size:16px;color:#000000;"><a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496b47b518fe04abddb472758c30d6c157de2c057fd1800d4ceb43bd8115714324ed9e11ecadeff44ecbbde3cc034be755f" target="_blank" style="color:#000000;text-decoration:none;font-weight:bold;">Listen to today&#8217;s Pulse Check podcast</a
></p></td>        </tr>        </tbody>    </table></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    </tr>                                    <tr>                        <td style="padding-bottom:10px; min-width:100%; width:100%;"><!-- Inline styling used, as its an email content --><table width="100%" cellpadding="0" cellspacing="0" border="0" role="presentation" style="background-color:#121522; min-width:100%;">    <tbody>    <tr>        
<td style="text-align:left;font-family:Helvetica,sans-serif;font-size:12px;color:#FFFFFF;text-transform:uppercase;font-weight:bold;letter-spacing:2px;padding-top:10px;padding-bottom:10px;padding-left:20px;margin:0;" valign="middle">DANGER ZONE </td>    </tr>    </tbody></table></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;">
<p align="center" style="margin:0 0 20px 0;"><img src="https://www.politico.com/dims4/default/b9ccbbb/2147483647/resize/1000x/quality/90/?url=https%3A%2F%2Fstatic.politico.com%2Fc9%2Fa2%2F19798fa740f5a7c7621070f86552%2F20220316-nj-school-kids-ap-700.jpg" title="20220316_NJ_School_kids_AP_700.jpg" alt="Students line up to enter Christa McAuliffe School in Jersey City, N.J. " width="500" style="width:100%;max-width:500px;"></p><p style="font-family:Helvetica,sans-serif;font-size:12px;color:#6E7381;margin-bottom:24px;">A new study paints a bleak picture of kids' mental health.  |  Seth Wenig/AP Photo</p></td>                    </tr>                                    
<tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">It&#8217;s common knowledge</strong
> that kids&#8217; mental health has declined, but new research measures the severity &#8212; and it&#8217;s bad.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">Between 2016 and 2022, kids and young adults saw inpatient hospital admissions related to mental health more than double, according to <a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb4961d36b4b71d5a2b821978f94aed3d0345a36f96d46209d9fa727a225ee058b76b4b07aacd62f8331f4526b41acd519ffd" target="_blank"><u>an analysis by the Clarify Health Institute</u></a
>.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">The hospital admission stats are grim:</strong
></p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">&#8212; Anxiety and &#8220;fear-related disorders&#8221; spiked 250 percent.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">&#8212; Eating disorders, including those related to an inability to eat, increased 221 percent.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">&#8212; Depression and related ailments went up 96 percent.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">&#8212; Suicide attempts, suicidal ideation and self-harm rose 74 percent.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">Diagnosis:</strong
> The pandemic and the measures used to control it appeared to worsen preexisting trends.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">The researchers also pointed to social media as a potential cause.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">Response: </strong
>The researchers said the rise in inpatient care is partly a result of the failures of outpatient providers early on.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">&#8220;The most effective approach to pediatric mental health care likely involves a combination of inpatient and outpatient services, with patients transitioning between levels of care based on their individual needs and the severity of their conditions,&#8221; the researchers said.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">Lawmakers in Washington have zeroed in on social media, but it&#8217;s unclear what tangible steps they&#8217;ll take.<br></p></td>                    
</tr>                                    <tr>                        </tr><tr>    <td height="10" style="height:10px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td></tr><tr>    <td style="padding:20px 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;background-color:#FFFFFF;">                                    <p style="margin-top:0;margin-bottom:20px;line-height:24px;margin-bottom:20px;color:#000000;">                <strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">GET READY FOR GLOBAL TECH DAY: </strong
>Join POLITICO Live as we launch our first Global Tech Day alongside London Tech Week on Thursday, June 15. Register now for continuing updates and to be a part of this momentous and program-packed day! From the blockchain, to AI, and autonomous vehicles, technology is changing how power is exercised around the world, so who will write the rules? <a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496897e92e879c9fbebaae9ba22ee2767fbd539c74b935ce3b2861a1268e6b4babd629aded2cc13cbfcaaf49b366805ffb7" target="_blank" style="text-decoration:underline;color:#007BC7;">REGISTER HERE</a
>.            </p>            </td></tr><tr>    <td height="10" style="height:10px; font-size:0; border-bottom:1px solid #E5E7EB;">&nbsp;</td></tr><tr>    <td height="15" style="height:15px; font-size:0;">&nbsp;</td></tr>                                                        <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    </tr>                                    <tr>                        <td style="padding-bottom:10px; min-width:100%; width:100%;"><!-- Inline styling used, as its an email content -->
<table width="100%" cellpadding="0" cellspacing="0" border="0" role="presentation" style="background-color:#121522; min-width:100%;">    <tbody>    <tr>        <td style="text-align:left;font-family:Helvetica,sans-serif;font-size:12px;color:#FFFFFF;text-transform:uppercase;font-weight:bold;letter-spacing:2px;padding-top:10px;padding-bottom:10px;padding-left:20px;margin:0;" valign="middle">WASHINGTON WATCH</td>    </tr>    </tbody></table></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    
</tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"><p align="center" style="margin:0 0 20px 0;"><img src="https://www.politico.com/dims4/default/5c826cd/2147483647/resize/1000x/quality/90/?url=https%3A%2F%2Fstatic.politico.com%2Fc1%2F88%2Fc6b335b749c8a12f011fa77980e9%2Felection-2024-virginia-senate-10099.jpg" title="20230215-Tim-Kane-AP" alt="Tim Kaine stands outside. " width="500" style="width:100%;max-width:500px;"></p>
<p style="font-family:Helvetica,sans-serif;font-size:12px;color:#6E7381;margin-bottom:24px;">Kaine wants to ensure the military is doing all it can to prevent fentanyl trafficking.  |  John C. Clark/AP Photo</p></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">GOP lawmakers have</strong
> introduced legislation <a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496aa8a4c33f5091c4f52454f585ac50d1e3307098d90760dc09c85f106acecbf3789b13cd6a97d9f3a8d20df545b08e03a" target="_blank"><u>to authorize the bombing of fentanyl labs</u></a
> in Mexico.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">That&#8217;s unacceptable to Democrats on Capitol Hill, but there is support in their caucus for increasing Pentagon involvement in the fight against the deadly synthetic opioid.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">How so? </strong
>Tim Kaine (D-Va.) plans to join his Republican colleague Joni Ernst of Iowa in asking fellow senators on the Armed Services Committee to add a provision to the National Defense Authorization Act naming fentanyl trafficking a national security threat, Kaine told POLITICO.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">The panel plans to consider the bill next month.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">It would direct the Pentagon to develop a counterdrug strategy. And it would task Defense Secretary Lloyd Austin with seeking more cooperation from the Mexican military.</p>
<p style="margin-top:0;margin-bottom:24px;line-height:24px;">Ernst told POLITICO in an email that the bill is &#8220;a real solution to the deadly fentanyl crisis with bipartisan, bicameral support.&#8221;</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">Why it matters: </strong
>Congress has passed a defense authorization bill <a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496b98980093a07a14c1412f2b98fe397d9feaaf20b758fb00dd95c8e404bf536354c4db0672c58ad3793c46c3be026a8aa" target="_blank"><u>for 62 consecutive years</u></a
>, so if Kaine and Ernst are successful, their amendment is likely to become law.</p></td>                    </tr>                                <!-- End Ad Copy -->                <tr>                                    </tr>                <!-- Post Body Content -->                <tr>                                    </tr>                <tr>                    <td height="20" style="height:20px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td>                </tr>                <!-- Twitter Handles -->                                    <tr>    <td style="color:#000000;padding:0px 20px 20px 20px;text-align:left;">        
<p style="font-family:Helvetica,sans-serif;font-size:20px;color:#000000;margin-top:0;margin-bottom:15px;"><strong
>Follow us on Twitter</strong
></p>        <table cellpadding="0" cellspacing="0" border="0" role="presentation">            <tbody>            <tr>                <td width="52" valign="middle" style="text-align:left;padding-right:10px;"><img src="https://static.politico.com/hosted/icon-twitter-circle-blue%402x.png" title="" alt="" width="50" style="max-width:50px;"></td>                <td valign="middle" style="text-align:left;font-family:Helvetica,sans-serif;font-size:14px;font-weight:bold;color:#000000;">                                            <p style="margin-top:0;margin-bottom:5px;line-height:14px;">Ben Leonard <a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496ca145841d793ff80ee9ad0b2756b82ea3dc70525c17275f71f6331b0e3631f45ff43583e7d451317e7289549a473fc3d" style="color:#007BC7;text-decoration:none;font-weight:bold;" target="_blank">@_BenLeonard_</a
></p>                                            <p style="margin-top:0;margin-bottom:5px;line-height:14px;">Ruth Reader <a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496ad1d47a8587ba460537f11648d60a86cf6c654d61507651de2c7802208ea4761719e842ee4a9d681784196e6ed3675db" style="color:#007BC7;text-decoration:none;font-weight:bold;" target="_blank">@RuthReader</a
></p>                                            <p style="margin-top:0;margin-bottom:5px;line-height:14px;">Carmen Paun <a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496041711503323dd78b0a799f4d5dcaa2f7eee790d8b0cb5e68cc44174aeb031e58e00913aab7367c54c73f2bff26d2723" style="color:#007BC7;text-decoration:none;font-weight:bold;" target="_blank">@carmenpaun</a
></p>                                            <p style="margin-top:0;margin-bottom:5px;line-height:14px;">Erin Schumaker <a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb49672e5ff2554c155fa66ad5170a194a9a4e887c28586b07eee04b5ad2e8323efecea43b990de83e4c45ca7563ea0210d86" style="color:#007BC7;text-decoration:none;font-weight:bold;" target="_blank">@erinlschumaker</a
></p>                                    </td>            </tr>            </tbody>        </table>    </td></tr><tr>    <td height="20" style="height:20px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td></tr>                                <!-- Family of Playbook -->                                <!-- Follow us -->                <tr>    <td style="color:#000000;padding:0px 20px 20px 20px;text-align:left;">        <p style="font-family:Helvetica,sans-serif;font-size:12px;color:#000000;margin-bottom:10px;line-height:14px;text-transform:uppercase;font-weight:bold;letter-spacing:2px;">Follow us</p>        
<table cellpadding="0" cellspacing="0" border="0" role="presentation">            <tbody>            <tr>                <td width="40" style="text-align:left;"><a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496c4bca1c13634108d4e9ceb5860174ee40227ee864b4d877719c9232bcd227a0fbf4b330791fb6409a4be6e361f5b6e37" target="_blank"><img src="https://static.politico.com/hosted/icon-follow-facebook-gray%402x.png" title="Follow us on Facebook" alt="Follow us on Facebook" width="24" border="0" style="max-width:24px;"></a
></td>                <td width="40" style="text-align:left;"><a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb4962303e7005dc01afeb8a6427cf9061866eb83650b686a21c0d8bbb8d1450a4b5969619fd20f548b555d3cdad75080200f" target="_blank"><img src="https://static.politico.com/hosted/icon-follow-twitter-gray%402x.png" title="Follow us on Twitter" alt="Follow us on Twitter" width="24" border="0" style="max-width:24px;"></a
></td>                <td width="40" style="text-align:left;"><a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb49685909f8b26d3188785bd55d901cadce4dd3c978ffb1d203abfe223a5781e14fa6cd858570cc4bbbdc07b4bd6b4706d1d" target="_blank"><img src="https://static.politico.com/hosted/icon-follow-instagram-gray%402x.png" title="Follow us on Instagram" alt="Follow us on Instagram" width="24" border="0" style="max-width:24px;"></a
></td>                <td width="40" style="text-align:left;"><a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496c2e2e2919e4aa7d20cc2a96cde8348c6a68be46abf54c43373666a2c41ee7f7356f35006b9cebf1bdf5c67b0cbde6e64" target="_blank"><img src="https://static.politico.com/hosted/icon-follow-applePodcast-gray%402x.png" title="Listen on Apple Podcast" alt="Listen on Apple Podcast" width="24" border="0" style="max-width:24px;"></a
></td>            </tr>            </tbody>        </table>    </td></tr><tr>    <td height="20" style="height:20px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td></tr>                </tbody>            </table>        </td>        <td><!-- Note: This is left blank to aid in centering across email clients --></td>    </tr>    </tbody></table><!-- Everything below this line is "new" to the template. We'll have to experiment a bit to see if it causes troubles. --><!-- howler#email.footers/core-newsletter.footer.html -->
<table border="0" cellpadding="0" cellspacing="0" width="100%" bgcolor="#ffffff"
       style="padding:5px 0 15px 0;margin:0;text-align:center" role="presentation">
    <tbody>
    <tr>
        <td><!-- Note: This is left blank to aid in centering across email clients --></td>
        <td align="center" width="540">
            <table width="100%" border="0" cellpadding="0" cellspacing="0" style="max-width:540px" role="presentation">
                <tbody>
                <tr>
                    <td align="center" style="font-family:Helvetica,sans-serif;font-size:14px;color:#000000;">
                        <p style="margin-bottom:15px;line-height:24px;">To change your alert settings, please log in at
                            <a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb496b0f31e4da595e336f3e14e7e8dcda5cf5f4b4875d3a40ba63ce5c2fce09e98af3bd2797779cec63d27ce424236f4384a" target="_blank" style="color:#007BC7;text-decoration:none;">https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings</a
>
                            <!--Commenting out the following line because it causes an undesired line to be displayed on outlook (some versions) and we couldn't find the use case of it-->
                            <!-- <span style="display:none;"><a
 href="https://click.politicoemail.com/profile_center.aspx?qs=9c775bb5bc5419bcb2e8309a5c29d12d93e82fe774a453a2aeb0863568da0b0445ea46dc136edbde9ea5dfeaf4c919f9">https://click.politicoemail.com/profile_center.aspx?qs=9c775bb5bc5419bcb2e8309a5c29d12d93e82fe774a453a2aeb0863568da0b0445ea46dc136edbde9ea5dfeaf4c919f9</a
></span> -->
                        </p>
                    </td>
                </tr>
                <tr>
                    <td align="center" style="padding-bottom:15px;"><img
                            src="https://static.politico.com/hosted/icon-politico-logo.png"
                            class="CToWUd"></td>
                </tr>
                <tr>
                    <td align="center"><p
                            style="font-family:Helvetica,sans-serif;font-size:14px;color:#000000;margin-bottom:15px;line-height:20px;">
                        This email was sent to ouchendans62@gmail.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA
                        <p style="font-family:Helvetica,sans-serif;font-size:14px;color:#000000;margin-bottom:15px;line-height:24px;">
                            

                            Please click <a
 href="https://go.politicoemail.com/?qs=d8a27c8b492fb4966887f419b300813f66d9351c6c0cd2b027986264ece5455eda3c2a43bff69659fa580790720668683a3915afa22e0140" target="_blank" style="color:#007BC7;text-decoration:none;">here</a
> and follow the steps to unsubscribe.
                        </p>
                    </td>
                </tr>
                </tbody>
            </table>
        </td>
        <td><!-- Note: This is left blank to aid in centering across email clients --></td>
    </tr>
    </tbody>
</table>
<img src="https://click.politicoemail.com/open.aspx?ffcb10-fe911d787565037f76-fdef13797160037e70177574-fe9115737262077c7c-fe891676726d017a77-fdf61574756104747317747c-ffcf14&d=40126&bmt=0" width="1" height="1" alt="">
</body></html><p email-meta style="display: none;opacity:0;">source=GoggleDocument, article=00000188-6a58-d191-afc8-6e5c4c6d0000</p>

--hsA5nR10H75w=_?:--

